<link>https://research.bidmc.org/rss.xml</link><description>Openscholar RSS Feeds will show latest apps, publications and terms on the site.</description><language>en</language><item><title>Stromal Steroid 5 α-Reductase Type 2 Promotes Prostate Growth through WNT5A-Lymphoid Enhancer-Binding Factor 1-Insulin-Like Growth Factor 1 Signaling in Benign Prostatic Hyperplasia.

<link>https://research.bidmc.org/rss.xml</link><description>Openscholar RSS Feeds will show latest apps, publications and terms on the site.</description><language>en</language><item><title>Stromal Steroid 5 α-Reductase Type 2 Promotes Prostate Growth through WNT5A-Lymphoid Enhancer-Binding Factor 1-Insulin-Like Growth Factor 1 Signaling in Benign Prostatic Hyperplasia.https://research.bidmc.org/aria-olumi/publications/stromal-steroid-5-reductase-type-2-promotes-prostate-growth-through-wnt5a-lymphoidjulieTuesday, March 5, 2024, 3:42pm12691 at https://research.bidmc.orgEctonucleotidases and purinergic receptors in mouse prostate glandhttps://research.bidmc.org/aria-olumi/publications/ectonucleotidases-and-purinergic-receptors-mouse-prostate-glandbgu@bidmc.harvard.eduTuesday, October 7, 2025, 4:57pm21438 at https://research.bidmc.orgLifetime Health and Economic Outcomes of Biparametric Magnetic Resonance Imaging as First-Line Screening for Prostate Cancer : A Decision Model Analysishttps://research.bidmc.org/aria-olumi/publications/lifetime-health-and-economic-outcomes-biparametric-magnetic-resonance-imaging-firstbgu@bidmc.harvard.eduTuesday, October 7, 2025, 4:57pm21439 at https://research.bidmc.orgPredicting cancer detection rates from multiparametric prostate MRI Beyond the PI-RADS classification systemhttps://research.bidmc.org/aria-olumi/publications/predicting-cancer-detection-rates-multiparametric-prostate-mri-beyond-pi-radsbgu@bidmc.harvard.eduTuesday, October 7, 2025, 4:57pm21440 at https://research.bidmc.orgEffect of TNF-α Inhibitor Therapy on Growth of the Prostate Glandhttps://research.bidmc.org/aria-olumi/publications/effect-tnf-inhibitor-therapy-growth-prostate-glandbgu@bidmc.harvard.eduTuesday, October 7, 2025, 4:57pm21441 at https://research.bidmc.orgExpression and distribution of activin-follistatin-inhibin axis in the urinary bladderhttps://research.bidmc.org/aria-olumi/publications/expression-and-distribution-activin-follistatin-inhibin-axis-urinary-bladderbgu@bidmc.harvard.eduTuesday, October 7, 2025, 4:57pm21442 at https://research.bidmc.orgComprehensive characterization of the real-world perioperative morbidity of radical cystectomy in older adultshttps://research.bidmc.org/aria-olumi/publications/comprehensive-characterization-real-world-perioperative-morbidity-radical-cystectomybgu@bidmc.harvard.eduTuesday, October 7, 2025, 4:57pm21443 at https://research.bidmc.orgEnhanced prostatic Esr1(+) luminal epithelial cells in the absence of SRD5A2https://research.bidmc.org/aria-olumi/publications/enhanced-prostatic-esr1-luminal-epithelial-cells-absence-srd5a2bgu@bidmc.harvard.eduTuesday, October 7, 2025, 4:57pm21444 at https://research.bidmc.orgPractical Use of Self-Adjusted Nitrous Oxide During Transrectal Prostate Biopsy: A Double-Blind Randomized Controlled Trialhttps://research.bidmc.org/aria-olumi/publications/practical-use-self-adjusted-nitrous-oxide-during-transrectal-prostate-biopsy-doublebgu@bidmc.harvard.eduTuesday, October 7, 2025, 4:57pm21445 at https://research.bidmc.orgThe association of patient and disease characteristics with the overtreatment of low-risk prostate cancer from 2010 to 2016https://research.bidmc.org/aria-olumi/publications/association-patient-and-disease-characteristics-overtreatment-low-risk-prostate-cancerbgu@bidmc.harvard.eduTuesday, October 7, 2025, 4:57pm21446 at https://research.bidmc.orgImmediate radiotherapy versus observation in patients with node-positive prostate cancer after radical prostatectomyhttps://research.bidmc.org/aria-olumi/publications/immediate-radiotherapy-versus-observation-patients-node-positive-prostate-cancer-afterbgu@bidmc.harvard.eduTuesday, October 7, 2025, 4:57pm21447 at https://research.bidmc.orgAssociations of a claims-based frailty index with perioperative outcomes and survival among older adults undergoing radical cystectomy for bladder cancerhttps://research.bidmc.org/aria-olumi/publications/associations-claims-based-frailty-index-perioperative-outcomes-and-survival-amongbgu@bidmc.harvard.eduTuesday, October 7, 2025, 4:57pm21448 at https://research.bidmc.orgExtended prostate needle biopsy improves concordance of Gleason grading between prostate needle biopsy and radical prostatectomyhttps://research.bidmc.org/aria-olumi/publications/extended-prostate-needle-biopsy-improves-concordance-gleason-grading-between-prostatebgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21449 at https://research.bidmc.orgThe relationship of prostate gland volume to extended needle biopsy on prostate cancer detectionhttps://research.bidmc.org/aria-olumi/publications/relationship-prostate-gland-volume-extended-needle-biopsy-prostate-cancer-detectionbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21450 at https://research.bidmc.orgPathologic quiz case. A symptomatic renal tumor. Juxtaglomerular cell tumorhttps://research.bidmc.org/aria-olumi/publications/pathologic-quiz-case-symptomatic-renal-tumor-juxtaglomerular-cell-tumorbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21451 at https://research.bidmc.orgSelf-retraction clamp for dissection of the posterior prostatic fossa during radical retropubic prostatectomyhttps://research.bidmc.org/aria-olumi/publications/self-retraction-clamp-dissection-posterior-prostatic-fossa-during-radical-retropubicbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21452 at https://research.bidmc.orgExpression of transforming growth factor-beta 1 and growth in soft agar differentiate prostate carcinoma-associated fibroblasts from normal prostate fibroblastshttps://research.bidmc.org/aria-olumi/publications/expression-transforming-growth-factor-beta-1-and-growth-soft-agar-differentiatebgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21453 at https://research.bidmc.orgPercent of cores positive for cancer is a better preoperative predictor of cancer recurrence after radical prostatectomy than prostate specific antigenhttps://research.bidmc.org/aria-olumi/publications/percent-cores-positive-cancer-better-preoperative-predictor-cancer-recurrence-afterbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21454 at https://research.bidmc.orgPersistent c-FLIP(L) expression is necessary and sufficient to maintain resistance to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in prostate cancerhttps://research.bidmc.org/aria-olumi/publications/persistent-c-flipl-expression-necessary-and-sufficient-maintain-resistance-tumorbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21455 at https://research.bidmc.orgUrothelial mucosal malformation: a rare cause for ureteropelvic junction obstructionhttps://research.bidmc.org/aria-olumi/publications/urothelial-mucosal-malformation-rare-cause-ureteropelvic-junction-obstructionbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21456 at https://research.bidmc.orgLow age adjusted free testosterone levels correlate with poorly differentiated prostate cancerhttps://research.bidmc.org/aria-olumi/publications/low-age-adjusted-free-testosterone-levels-correlate-poorly-differentiated-prostatebgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21457 at https://research.bidmc.orgSurgical management of scrotal lymphedema using local flapshttps://research.bidmc.org/aria-olumi/publications/surgical-management-scrotal-lymphedema-using-local-flapsbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21458 at https://research.bidmc.orgNovel targeted pro-apoptotic agents for the treatment of prostate cancerhttps://research.bidmc.org/aria-olumi/publications/novel-targeted-pro-apoptotic-agents-treatment-prostate-cancerbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21459 at https://research.bidmc.orgHypoxia-inducible factor linked to differential kidney cancer risk seen with type 2A and type 2B VHL mutationshttps://research.bidmc.org/aria-olumi/publications/hypoxia-inducible-factor-linked-differential-kidney-cancer-risk-seen-type-2a-and-typebgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21460 at https://research.bidmc.orgStromally expressed c-Jun regulates proliferation of prostate epithelial cellshttps://research.bidmc.org/aria-olumi/publications/stromally-expressed-c-jun-regulates-proliferation-prostate-epithelial-cellsbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21461 at https://research.bidmc.orgMG-132 sensitizes TRAIL-resistant prostate cancer cells by activating c-Fos/c-Jun heterodimers and repressing c-FLIP(L)https://research.bidmc.org/aria-olumi/publications/mg-132-sensitizes-trail-resistant-prostate-cancer-cells-activating-c-fosc-junbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21462 at https://research.bidmc.orgpVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2https://research.bidmc.org/aria-olumi/publications/pvhl-acts-adaptor-promote-inhibitory-phosphorylation-nf-kappab-agonist-card9-ck2bgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21463 at https://research.bidmc.orgLexatumumab (TRAIL-receptor 2 mAb) induces expression of DR5 and promotes apoptosis in primary and metastatic renal cell carcinoma in a mouse orthotopic modelhttps://research.bidmc.org/aria-olumi/publications/lexatumumab-trail-receptor-2-mab-induces-expression-dr5-and-promotes-apoptosis-primarybgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21464 at https://research.bidmc.orgLow-dose 12-O-tetradecanoylphorbol-13-acetate enhances tumor necrosis factor related apoptosis-inducing ligand induced apoptosis in prostate cancer cellshttps://research.bidmc.org/aria-olumi/publications/low-dose-12-o-tetradecanoylphorbol-13-acetate-enhances-tumor-necrosis-factor-relatedbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21465 at https://research.bidmc.orgc-Fos as a proapoptotic agent in TRAIL-induced apoptosis in prostate cancer cellshttps://research.bidmc.org/aria-olumi/publications/c-fos-proapoptotic-agent-trail-induced-apoptosis-prostate-cancer-cellsbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21466 at https://research.bidmc.orgMR imaging of renal masses: correlation with findings at surgery and pathologic analysishttps://research.bidmc.org/aria-olumi/publications/mr-imaging-renal-masses-correlation-findings-surgery-and-pathologic-analysisbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21467 at https://research.bidmc.orgOvercoming resistance to trail-induced apoptosis in prostate cancer by regulation of c-FLIPhttps://research.bidmc.org/aria-olumi/publications/overcoming-resistance-trail-induced-apoptosis-prostate-cancer-regulation-c-flipbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21468 at https://research.bidmc.orgInvolvement of FLIP in 2-methoxyestradiol-induced tumor regression in transgenic adenocarcinoma of mouse prostate modelhttps://research.bidmc.org/aria-olumi/publications/involvement-flip-2-methoxyestradiol-induced-tumor-regression-transgenic-adenocarcinomabgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21469 at https://research.bidmc.orgThe hybrid of basic science and clinical training for the urologic oncologist: Necessity or waste?https://research.bidmc.org/aria-olumi/publications/hybrid-basic-science-and-clinical-training-urologic-oncologist-necessity-or-wastebgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21470 at https://research.bidmc.orgRepression of NF-kappaB and activation of AP-1 enhance apoptosis in prostate cancer cellshttps://research.bidmc.org/aria-olumi/publications/repression-nf-kappab-and-activation-ap-1-enhance-apoptosis-prostate-cancer-cellsbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21471 at https://research.bidmc.orgReduced levels of 5-α reductase 2 in adult prostate tissue and implications for BPH therapyhttps://research.bidmc.org/aria-olumi/publications/reduced-levels-5-reductase-2-adult-prostate-tissue-and-implications-bph-therapybgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21472 at https://research.bidmc.orgMen with organ-confined prostate cancer and positive surgical margins develop biochemical failure at a similar rate to men with extracapsular extensionhttps://research.bidmc.org/aria-olumi/publications/men-organ-confined-prostate-cancer-and-positive-surgical-margins-develop-biochemicalbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21473 at https://research.bidmc.orgDiabetes, growth hormone-insulin-like growth factor pathways and association to benign prostatic hyperplasiahttps://research.bidmc.org/aria-olumi/publications/diabetes-growth-hormone-insulin-growth-factor-pathways-and-association-benignbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21474 at https://research.bidmc.orgMultidisciplinary care and pursuit of active surveillance in low-risk prostate cancerhttps://research.bidmc.org/aria-olumi/publications/multidisciplinary-care-and-pursuit-active-surveillance-low-risk-prostate-cancerbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21475 at https://research.bidmc.orgImpact on the clinical outcome of prostate cancer by the 2005 international society of urological pathology modified Gleason grading systemhttps://research.bidmc.org/aria-olumi/publications/impact-clinical-outcome-prostate-cancer-2005-international-society-urologicalbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21476 at https://research.bidmc.orgA close surgical margin after radical prostatectomy is an independent predictor of recurrencehttps://research.bidmc.org/aria-olumi/publications/close-surgical-margin-after-radical-prostatectomy-independent-predictor-recurrencebgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21477 at https://research.bidmc.orgManagement of spermatic cord tumors: a rare urologic malignancyhttps://research.bidmc.org/aria-olumi/publications/management-spermatic-cord-tumors-rare-urologic-malignancybgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21478 at https://research.bidmc.orgInhibition of TNF-α improves the bladder dysfunction that is associated with type 2 diabeteshttps://research.bidmc.org/aria-olumi/publications/inhibition-tnf-improves-bladder-dysfunction-associated-type-2-diabetesbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21479 at https://research.bidmc.orgModels of care and NCCN guideline adherence in very-low-risk prostate cancerhttps://research.bidmc.org/aria-olumi/publications/models-care-and-nccn-guideline-adherence-very-low-risk-prostate-cancerbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21480 at https://research.bidmc.orgMetformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolismhttps://research.bidmc.org/aria-olumi/publications/metformin-decreases-glucose-oxidation-and-increases-dependency-prostate-cancer-cellsbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21481 at https://research.bidmc.orgIn vivo HIF-mediated reductive carboxylation is regulated by citrate levels and sensitizes VHL-deficient cells to glutamine deprivationhttps://research.bidmc.org/aria-olumi/publications/vivo-hif-mediated-reductive-carboxylation-regulated-citrate-levels-and-sensitizes-vhlbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21482 at https://research.bidmc.orgSmaller prostate gland size and older age predict Gleason score upgradinghttps://research.bidmc.org/aria-olumi/publications/smaller-prostate-gland-size-and-older-age-predict-gleason-score-upgradingbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21483 at https://research.bidmc.orgCase records of the Massachusetts General Hospital. Case 25-2013. A 71-year-old man with hematuria and a mass in the bladderhttps://research.bidmc.org/aria-olumi/publications/case-records-massachusetts-general-hospital-case-25-2013-71-year-old-man-hematuria-andbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21484 at https://research.bidmc.orgMedical oncology consultation and minimization of overtreatment in men with low-risk prostate cancerhttps://research.bidmc.org/aria-olumi/publications/medical-oncology-consultation-and-minimization-overtreatment-men-low-risk-prostatebgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21485 at https://research.bidmc.orgPersonalized medicine for the management of benign prostatic hyperplasiahttps://research.bidmc.org/aria-olumi/publications/personalized-medicine-management-benign-prostatic-hyperplasiabgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21486 at https://research.bidmc.orgMetformin use and prostate cancer riskhttps://research.bidmc.org/aria-olumi/publications/metformin-use-and-prostate-cancer-riskbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21487 at https://research.bidmc.org5α-Reductase inhibitors and risk of high-grade or lethal prostate cancerhttps://research.bidmc.org/aria-olumi/publications/5a-reductase-inhibitors-and-risk-high-grade-or-lethal-prostate-cancerbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21488 at https://research.bidmc.orgPrimary spermatic cord tumors: disease characteristics, prognostic factors, and treatment outcomeshttps://research.bidmc.org/aria-olumi/publications/primary-spermatic-cord-tumors-disease-characteristics-prognostic-factors-and-treatmentbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21489 at https://research.bidmc.orgClinical features of leiomyosarcoma of the urinary bladder: analysis of 183 caseshttps://research.bidmc.org/aria-olumi/publications/clinical-features-leiomyosarcoma-urinary-bladder-analysis-183-casesbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21490 at https://research.bidmc.orgPrognostic significance of indeterminate lung nodules in renal cell carcinomahttps://research.bidmc.org/aria-olumi/publications/prognostic-significance-indeterminate-lung-nodules-renal-cell-carcinomabgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21491 at https://research.bidmc.orgInhibition of PP2A activity confers a TRAIL-sensitive phenotype during malignant transformationhttps://research.bidmc.org/aria-olumi/publications/inhibition-pp2a-activity-confers-trail-sensitive-phenotype-during-malignantbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21492 at https://research.bidmc.orgAge and Obesity Promote Methylation and Suppression of 5α-Reductase 2: Implications for Personalized Therapy of Benign Prostatic Hyperplasiahttps://research.bidmc.org/aria-olumi/publications/age-and-obesity-promote-methylation-and-suppression-5a-reductase-2-implicationsbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21493 at https://research.bidmc.orgSuccinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinomahttps://research.bidmc.org/aria-olumi/publications/succinate-dehydrogenase-b-new-prognostic-biomarker-clear-cell-renal-cell-carcinomabgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21494 at https://research.bidmc.orgDNA methyl transferase 1 reduces expression of SRD5A2 in the aging adult prostatehttps://research.bidmc.org/aria-olumi/publications/dna-methyl-transferase-1-reduces-expression-srd5a2-aging-adult-prostatebgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21495 at https://research.bidmc.orgMetformin represses cancer cells via alternate pathways in N-cadherin expressing vs. N-cadherin deficient cellshttps://research.bidmc.org/aria-olumi/publications/metformin-represses-cancer-cells-alternate-pathways-n-cadherin-expressing-vs-nbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21496 at https://research.bidmc.orgActivation of AKR1C1/ERβ induces apoptosis by downregulation of c-FLIP in prostate cancer cells: A prospective therapeutic opportunityhttps://research.bidmc.org/aria-olumi/publications/activation-akr1c1erb-induces-apoptosis-downregulation-c-flip-prostate-cancer-cellsbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21497 at https://research.bidmc.orgUnderstanding temporal trends in medical costs associated with progression to metastatic prostate cancerhttps://research.bidmc.org/aria-olumi/publications/understanding-temporal-trends-medical-costs-associated-progression-metastatic-prostatebgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21498 at https://research.bidmc.orgRisk Factors for Disease Progression After Postprostatectomy Salvage Radiation: Long-term Results of a Single-institution Experiencehttps://research.bidmc.org/aria-olumi/publications/risk-factors-disease-progression-after-postprostatectomy-salvage-radiation-long-termbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21499 at https://research.bidmc.orgAndrogenic to oestrogenic switch in the human adult prostate gland is regulated by epigenetic silencing of steroid 5α-reductase 2https://research.bidmc.org/aria-olumi/publications/androgenic-oestrogenic-switch-human-adult-prostate-gland-regulated-epigeneticbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:03pm21500 at https://research.bidmc.orgMetformin inhibits the proliferation of benign prostatic epithelial cellshttps://research.bidmc.org/aria-olumi/publications/metformin-inhibits-proliferation-benign-prostatic-epithelial-cellsbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21501 at https://research.bidmc.orgProstate cancer in transgender womenhttps://research.bidmc.org/aria-olumi/publications/prostate-cancer-transgender-womenbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21502 at https://research.bidmc.orgPARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53https://research.bidmc.org/aria-olumi/publications/parp-1-inhibition-or-without-ionizing-radiation-confers-reactive-oxygen-speciesbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21503 at https://research.bidmc.orgEstradiol signaling mediates gender difference in visceral adiposity via autophagyhttps://research.bidmc.org/aria-olumi/publications/estradiol-signaling-mediates-gender-difference-visceral-adiposity-autophagybgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21504 at https://research.bidmc.orgMetabolomic Prediction of Human Prostate Cancer Aggressiveness: Magnetic Resonance Spectroscopy of Histologically Benign Tissuehttps://research.bidmc.org/aria-olumi/publications/metabolomic-prediction-human-prostate-cancer-aggressiveness-magnetic-resonancebgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21505 at https://research.bidmc.orgMetformin: an antiproliferative agent and methylation regulator in treating prostatic disease?https://research.bidmc.org/aria-olumi/publications/metformin-antiproliferative-agent-and-methylation-regulator-treating-prostatic-diseasebgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21506 at https://research.bidmc.orgExpression of aromatase in tumor related stroma is associated with human bladder cancer progressionhttps://research.bidmc.org/aria-olumi/publications/expression-aromatase-tumor-related-stroma-associated-human-bladder-cancer-progressionbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21507 at https://research.bidmc.orgBRCA1 Interacting Protein COBRA1 Facilitates Adaptation to Castrate-Resistant Growth Conditionshttps://research.bidmc.org/aria-olumi/publications/brca1-interacting-protein-cobra1-facilitates-adaptation-castrate-resistant-growthbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21508 at https://research.bidmc.orgWould You Recommend Prostate-Specific Antigen Screening for This Patient?: Grand Rounds Discussion From Beth Israel Deaconess Medical Centerhttps://research.bidmc.org/aria-olumi/publications/would-you-recommend-prostate-specific-antigen-screening-patient-grand-roundsbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21509 at https://research.bidmc.orgAssessment of 5-year overall survival in bladder cancer patients with incidental prostate cancer identified at radical cystoprostatectomyhttps://research.bidmc.org/aria-olumi/publications/assessment-5-year-overall-survival-bladder-cancer-patients-incidental-prostate-cancerbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21510 at https://research.bidmc.orgImpact of Multifocality and Multilocation of Positive Surgical Margin After Radical Prostatectomy on Predicting Oncological Outcomehttps://research.bidmc.org/aria-olumi/publications/impact-multifocality-and-multilocation-positive-surgical-margin-after-radicalbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21511 at https://research.bidmc.orgImpact of biopsy perineural invasion on the outcomes of patients who underwent radical prostatectomy: a systematic review and meta-analysishttps://research.bidmc.org/aria-olumi/publications/impact-biopsy-perineural-invasion-outcomes-patients-who-underwent-radicalbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21512 at https://research.bidmc.orgIntegrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypeshttps://research.bidmc.org/aria-olumi/publications/integrative-multiplatform-molecular-profiling-benign-prostatic-hyperplasia-identifiesbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21513 at https://research.bidmc.orgThe Role of Lymphadenectomy in Patients with Advanced Renal Cell Carcinomahttps://research.bidmc.org/aria-olumi/publications/role-lymphadenectomy-patients-advanced-renal-cell-carcinomabgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21514 at https://research.bidmc.orgMethylation of SRD5A2 promoter predicts a better outcome for castration-resistant prostate cancer patients undergoing androgen deprivation therapyhttps://research.bidmc.org/aria-olumi/publications/methylation-srd5a2-promoter-predicts-better-outcome-castration-resistant-prostatebgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21515 at https://research.bidmc.orgLong-term Oncologic Impact of Positive Anterior and Posterior Surgical Margins After Radical Prostatectomyhttps://research.bidmc.org/aria-olumi/publications/long-term-oncologic-impact-positive-anterior-and-posterior-surgical-margins-afterbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21516 at https://research.bidmc.orgObesity-associated inflammation induces androgenic to estrogenic switch in the prostate glandhttps://research.bidmc.org/aria-olumi/publications/obesity-associated-inflammation-induces-androgenic-estrogenic-switch-prostate-glandbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21517 at https://research.bidmc.orgHigh Real-World Medication Adherence and Durable Clinical Benefit in Medicare Patients Treated with 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasiahttps://research.bidmc.org/aria-olumi/publications/high-real-world-medication-adherence-and-durable-clinical-benefit-medicare-patientsbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21518 at https://research.bidmc.orgAdvancing bladder preservation: Biomarkers, decision-making, and therapyhttps://research.bidmc.org/aria-olumi/publications/advancing-bladder-preservation-biomarkers-decision-making-and-therapybgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21519 at https://research.bidmc.orgThe impact of pretreatment PSA on risk stratification in men with Gleason 6 prostate cancer: Implications for active surveillancehttps://research.bidmc.org/aria-olumi/publications/impact-pretreatment-psa-risk-stratification-men-gleason-6-prostate-cancer-implicationsbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21520 at https://research.bidmc.orgRadical prostatectomy versus external beam radiation therapy for high-grade, clinically localized prostate cancer: Emulation of a target clinical trialhttps://research.bidmc.org/aria-olumi/publications/radical-prostatectomy-versus-external-beam-radiation-therapy-high-grade-clinicallybgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21521 at https://research.bidmc.orgSirt1 coordinates with ERα to regulate autophagy and adiposityhttps://research.bidmc.org/aria-olumi/publications/sirt1-coordinates-era-regulate-autophagy-and-adipositybgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21522 at https://research.bidmc.orgContemporary Incidence and Predictors of Occult Inguinal Lymph Node Metastases in Men With Clinically Node-negative (cN0) Penile Cancerhttps://research.bidmc.org/aria-olumi/publications/contemporary-incidence-and-predictors-occult-inguinal-lymph-node-metastases-menbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21523 at https://research.bidmc.orgErratum. Inhibition of TNF-α Improves the Bladder Dysfunction That Is Associated With Type 2 Diabetes. Diabetes 2012;61:2134-2145https://research.bidmc.org/aria-olumi/publications/erratum-inhibition-tnf-improves-bladder-dysfunction-associated-type-2-diabetesbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21524 at https://research.bidmc.orgAdjuvant chemotherapy versus observation following radical cystectomy for locally advanced urothelial carcinoma of the bladderhttps://research.bidmc.org/aria-olumi/publications/adjuvant-chemotherapy-versus-observation-following-radical-cystectomy-locally-advancedbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21525 at https://research.bidmc.orgAdjuvant Chemotherapy Plus Radiotherapy versus Chemotherapy Alone for Locally Advanced Bladder Cancer after Radical Cystectomyhttps://research.bidmc.org/aria-olumi/publications/adjuvant-chemotherapy-plus-radiotherapy-versus-chemotherapy-alone-locally-advancedbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21526 at https://research.bidmc.orgSingle black men have the worst prognosis with localized prostate cancerhttps://research.bidmc.org/aria-olumi/publications/single-black-men-have-worst-prognosis-localized-prostate-cancerbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21527 at https://research.bidmc.orgZonal Growth Pattern of the Prostate Is Affected by Age and Body Mass Indexhttps://research.bidmc.org/aria-olumi/publications/zonal-growth-pattern-prostate-affected-age-and-body-mass-indexbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21528 at https://research.bidmc.orgRadical cystectomy versus trimodality therapy for muscle-invasive urothelial carcinoma of the bladderhttps://research.bidmc.org/aria-olumi/publications/radical-cystectomy-versus-trimodality-therapy-muscle-invasive-urothelial-carcinomabgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21529 at https://research.bidmc.org5-Alpha Reductase Inhibitors and Prostate Cancer Mortality among Men with Regular Access to Screening and Health Carehttps://research.bidmc.org/aria-olumi/publications/5-alpha-reductase-inhibitors-and-prostate-cancer-mortality-among-men-regular-accessbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21530 at https://research.bidmc.orgDisparities in the prevalence and management of high-risk non-muscle invasive bladder cancerhttps://research.bidmc.org/aria-olumi/publications/disparities-prevalence-and-management-high-risk-non-muscle-invasive-bladder-cancerbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21531 at https://research.bidmc.orgConditional survival following radical cystectomy for urothelial carcinoma of the bladderhttps://research.bidmc.org/aria-olumi/publications/conditional-survival-following-radical-cystectomy-urothelial-carcinoma-bladderbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21532 at https://research.bidmc.orgUrothelial carcinoma of the bladder with isolated lymph node metastasis: Natural history and outcomes following surgical resectionhttps://research.bidmc.org/aria-olumi/publications/urothelial-carcinoma-bladder-isolated-lymph-node-metastasis-natural-history-andbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21533 at https://research.bidmc.orgComparative Effectiveness of Magnetic Resonance Imaging-Ultrasound Fusion Versus In-bore Magnetic Resonance Imaging-targeted Prostate Biopsyhttps://research.bidmc.org/aria-olumi/publications/comparative-effectiveness-magnetic-resonance-imaging-ultrasound-fusion-versus-borebgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21534 at https://research.bidmc.orgCorrection: Sirt1 coordinates with ERα to regulate autophagy and adiposityhttps://research.bidmc.org/aria-olumi/publications/correction-sirt1-coordinates-era-regulate-autophagy-and-adipositybgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21535 at https://research.bidmc.orgCorrection: Metformin inhibits the proliferation of benign prostatic epithelial cellshttps://research.bidmc.org/aria-olumi/publications/correction-metformin-inhibits-proliferation-benign-prostatic-epithelial-cellsbgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21536 at https://research.bidmc.orgEffect of TNF-α Inhibitor Therapy on Growth of the Prostate Glandhttps://research.bidmc.org/aria-olumi/publications/effect-tnf-inhibitor-therapy-growth-prostate-gland-0bgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21537 at https://research.bidmc.orgPractical Use of Self-Adjusted Nitrous Oxide During Transrectal Prostate Biopsy: A Double-Blind Randomized Controlled Trialhttps://research.bidmc.org/aria-olumi/publications/practical-use-self-adjusted-nitrous-oxide-during-transrectal-prostate-biopsy-double-0bgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21538 at https://research.bidmc.orgImmediate radiotherapy versus observation in patients with node-positive prostate cancer after radical prostatectomyhttps://research.bidmc.org/aria-olumi/publications/immediate-radiotherapy-versus-observation-patients-node-positive-prostate-cancer-0bgu@bidmc.harvard.eduTuesday, October 7, 2025, 5:04pm21539 at https://research.bidmc.org<![CDATA[<p>Induction of ferroptosis in prostate cancer by CCDC7<sub>19-13</sub> via TRIM21-mediated ubiquitination of SLC7A11.</p>]]>https://research.bidmc.org/aria-olumi/publications/induction-ferroptosis-prostate-cancer-ccdc719-13-trim21-mediated-ubiquitinationzwang12@bidmc.harvard.eduThursday, October 9, 2025, 3:41pm21544 at https://research.bidmc.orgInduction of ferroptosis in prostate cancer by CCDC7(19-13) via TRIM21-mediated ubiquitination of SLC7A11https://research.bidmc.org/aria-olumi/publications/induction-ferroptosis-prostate-cancer-ccdc719-13-trim21-mediated-ubiquitination-0bgu@bidmc.harvard.eduFriday, October 10, 2025, 2:37pm21546 at https://research.bidmc.org